{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:13:00Z","timestamp":1771841580308,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Adult T-cell Leukemia\/Lymphoma (ATLL) is a rapidly progressing type of T-cell non-Hodgkin lymphoma that is developed after the infection by human T-cell leukemia virus type 1 (HTLV-1). It could be categorized into four major subtypes, acute, lymphoma, chronic, and smoldering. These different subtypes have some shared clinical manifestations, and there are no trustworthy biomarkers for diagnosis of them.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We applied weighted-gene co-expression network analysis to find the potential gene and miRNA biomarkers for various ATLL subtypes. Afterward, we found reliable miRNA-gene interactions by identifying the experimentally validated-target genes of miRNAs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The outcomes disclosed the interactions of miR-29b-2-5p and miR-342-3p with<jats:italic>LSAMP<\/jats:italic>in ATLL_acute, miR-575 with<jats:italic>UBN2<\/jats:italic>, miR-342-3p with<jats:italic>ZNF280B<\/jats:italic>, and miR-342-5p with<jats:italic>FOXRED2<\/jats:italic>in ATLL_chronic, miR-940 and miR-423-3p with C6orf141, miR-940 and miR-1225-3p with<jats:italic>CDCP1<\/jats:italic>, and miR-324-3p with<jats:italic>COL14A1<\/jats:italic>in ATLL_smoldering. These miRNA-gene interactions determine the molecular factors involved in the pathogenesis of each ATLL subtype and the unique ones could be considered biomarkers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The above-mentioned miRNAs-genes interactions are suggested as diagnostic biomarkers for different ATLL subtypes.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12920-023-01492-0","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T10:03:21Z","timestamp":1679997801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Potential miRNA-gene interactions determining progression of various ATLL cancer subtypes after infection by HTLV-1 oncovirus"],"prefix":"10.1186","volume":"16","author":[{"given":"Mohadeseh Zarei","family":"Ghobadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaheh","family":"Afsaneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahman","family":"Emamzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Soroush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"issue":"1","key":"1492_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-021-01643-8","volume":"18","author":"M Zarei Ghobadi","year":"2021","unstructured":"Zarei Ghobadi M, Emamzadeh R, Teymoori-Rad M, Mozhgani S-H. Decoding pathogenesis factors involved in the progression of ATLL or HAM\/TSP after infection by HTLV-1 through a systems virology study. Virol J. 2021;18(1):1\u201312.","journal-title":"Virol J"},{"issue":"12","key":"1492_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3390\/v10120691","volume":"10","author":"N Futsch","year":"2018","unstructured":"Futsch N, Prates G, Mahieux R, Casseb J, Dutartre H. Cytokine networks dysregulation during HTLV-1 infection and associated diseases. Viruses. 2018;10(12):691.","journal-title":"Viruses"},{"issue":"6","key":"1492_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1182\/bloodadvances.2017011106","volume":"2","author":"L Malpica","year":"2018","unstructured":"Malpica L, Pimentel A, Reis IM, Gotuzzo E, Lekakis L, Komanduri K, Harrington T, Barber GN, Ramos JC. Epidemiology, clinical features, and outcome of HTLV-1\u2013related ATLL in an area of prevalence in the United States. Blood Adv. 2018;2(6):607\u201320.","journal-title":"Blood Adv"},{"issue":"2","key":"1492_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.5858\/arpa.2012-0379-RS","volume":"138","author":"S Qayyum","year":"2014","unstructured":"Qayyum S, Choi JK. Adult T-cell leukemia\/lymphoma. Archives of Pathology Laboratory Medicine. 2014;138(2):282\u20136.","journal-title":"Archives of Pathology Laboratory Medicine"},{"issue":"8","key":"1492_CR5","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/bmt.2011.27","volume":"46","author":"M Jabbour","year":"2011","unstructured":"Jabbour M, Tuncer H, Castillo J, Butera J, Roy T, Pojani J, Al-Malki M, Al-Homsi A. Hematopoietic SCT for adult T-cell leukemia\/lymphoma: a review. Bone Marrow Transplant. 2011;46(8):1039\u201344.","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"1492_CR6","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.3390\/v7072805","volume":"7","author":"R Moles","year":"2015","unstructured":"Moles R, Nicot C. The emerging role of miRNAs in HTLV-1 infection and ATLL pathogenesis. Viruses. 2015;7(7):4047\u201374.","journal-title":"Viruses"},{"issue":"4","key":"1492_CR7","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.18632\/oncotarget.23539","volume":"9","author":"F Ye","year":"2018","unstructured":"Ye F. MicroRNA expression and activity in T-cell acute lymphoblastic leukemia. OncoTargets. 2018;9(4):5445.","journal-title":"OncoTargets"},{"issue":"2","key":"1492_CR8","doi-asserted-by":"publisher","first-page":"e0247713","DOI":"10.1371\/journal.pone.0247713","volume":"16","author":"MZ Ghobadi","year":"2021","unstructured":"Ghobadi MZ, Emamzadeh R, Mozhgani S-H. Deciphering microRNA-mRNA regulatory network in adult T-cell leukemia\/lymphoma; the battle between oncogenes and anti-oncogenes. PLoS ONE. 2021;16(2):e0247713.","journal-title":"PLoS ONE"},{"issue":"1","key":"1492_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-022-09540-1","volume":"22","author":"MZ Ghobadi","year":"2022","unstructured":"Ghobadi MZ, Emamzadeh R, Afsaneh E. Exploration of mRNAs and miRNA classifiers for various ATLL cancer subtypes using machine learning. BMC Cancer. 2022;22(1):1\u20138.","journal-title":"BMC Cancer"},{"issue":"1","key":"1492_CR10","doi-asserted-by":"publisher","first-page":"e0262739","DOI":"10.1371\/journal.pone.0262739","volume":"17","author":"M Zarei Ghobadi","year":"2022","unstructured":"Zarei Ghobadi M, Emamzadeh R. Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM\/TSP). PLoS ONE. 2022;17(1):e0262739.","journal-title":"PLoS ONE"},{"key":"1492_CR11","doi-asserted-by":"publisher","first-page":"198875","DOI":"10.1016\/j.virusres.2022.198875","volume":"319","author":"S-H Mozhgani","year":"2022","unstructured":"Mozhgani S-H, Ghobadi MZ, Norouzi M, Rahimi H, Valizadeh N, Teymoori-Rad M, Tarokhian H, Ostadali M, Farajifard H, Rezaee SA. Signaling factors potentially associated to the pathogenesis of adult T-cell leukemia\/lymphoma: a network-analysis and novel findings assessment. Virus Res. 2022;319:198875.","journal-title":"Virus Res"},{"issue":"1","key":"1492_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-021-00390-3","volume":"16","author":"S Shadabi","year":"2021","unstructured":"Shadabi S, Delrish N, Norouzi M, Ehteshami M, Habibian-Sezavar F, Pourrezaei S, Madihi M, Ostadali M, Akhgar F, Shayeghpour A. Comprehensive high-throughput meta-analysis of differentially expressed microRNAs in transcriptomic datasets reveals significant disruption of MAPK\/JNK signal transduction pathway in adult T-cell leukemia\/lymphoma. Infect Agents Cancer. 2021;16(1):1\u201310.","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"1492_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","volume":"21","author":"M Yamagishi","year":"2012","unstructured":"Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, Matsuda Y, Sato-Otsubo A, Muto S, Utsunomiya A. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-\u03baB pathway in adult T cell leukemia and other cancers. Cancer Cell Int. 2012;21(1):121\u201335.","journal-title":"Cancer Cell Int"},{"issue":"14","key":"1492_CR14","first-page":"1790","volume":"127","author":"D Fujikawa","year":"2016","unstructured":"Fujikawa D, Nakagawa S, Hori M, Kurokawa N, Soejima A, Nakano K, Yamochi T, Nakashima M, Kobayashi S, Tanaka Y. Polycomb-dependent epigenetic landscape in adult T-cell leukemia. Blood The Journal of the American Society of Hematology. 2016;127(14):1790\u2013802.","journal-title":"Blood The Journal of the American Society of Hematology"},{"issue":"1","key":"1492_CR15","doi-asserted-by":"publisher","first-page":"e1002480","DOI":"10.1371\/journal.ppat.1002480","volume":"8","author":"S Tattermusch","year":"2012","unstructured":"Tattermusch S, Skinner JA, Chaussabel D, Banchereau J, Berry MP, McNab FW, O\u2019Garra A, Taylor GP, Bangham CR. Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathog. 2012;8(1):e1002480.","journal-title":"PLoS Pathog"},{"issue":"21","key":"1492_CR16","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.1158\/0008-5472.CAN-13-3564","volume":"74","author":"C Vernin","year":"2014","unstructured":"Vernin C, Thenoz M, Pinatel C, Gessain A, Gout O, Delfau-Larue M-H, Nazaret N, Legras-Lachuer C, Wattel E, Mortreux F. HTLV-1 bZIP factor HBZ promotes cell proliferation and genetic instability by activating OncomiRs. Cancer Res. 2014;74(21):6082\u201393.","journal-title":"Cancer Res"},{"issue":"1","key":"1492_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1186\/s12967-022-03826-5","volume":"20","author":"J Liu","year":"2022","unstructured":"Liu J, Liu S, Yu Z, Qiu X, Jiang R, Li W. Uncovering the gene regulatory network of type 2 diabetes through multi-omic data integration. J Translational Med. 2022;20(1):604.","journal-title":"J Translational Med"},{"issue":"1","key":"1492_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12943-022-01658-x","volume":"21","author":"Z Pan","year":"2022","unstructured":"Pan Z, Xu T, Bao L, Hu X, Jin T, Chen J, Chen J, Qian Y, Lu X, li L, et al. CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment. Mol Cancer. 2022;21(1):190.","journal-title":"Mol Cancer"},{"key":"1492_CR19","doi-asserted-by":"crossref","unstructured":"Wang T, Zeng F, Li X, Wei Y, Wang D, Zhang W, Xie H, Wei L, Xiong S, Liu CJCR. Identification of key genes and pathways associated with sex differences in rheumatoid arthritis based on bioinformatics analysis. 2022:1\u20138.","DOI":"10.1007\/s10067-022-06387-6"},{"key":"1492_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jad.2021.08.005","volume":"295","author":"S He","year":"2021","unstructured":"He S, Deng Z, Li Z, Gao W, Zeng D, Shi Y, Zhao N, Xu F, Li T, Li H. Signatures of 4 autophagy-related genes as diagnostic markers of MDD and their correlation with immune infiltration. J Affect Disord. 2021;295:11\u201320.","journal-title":"J Affect Disord"},{"issue":"5","key":"1492_CR21","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10142-022-00881-5","volume":"22","author":"K De Silva","year":"2022","unstructured":"De Silva K, Demmer RT, J\u00f6nsson D, Mousa A, Forbes A, Enticott J. Highly perturbed genes and hub genes associated with type 2 diabetes in different tissues of adult humans: a bioinformatics analytic workflow. Funct Integr Genomics. 2022;22(5):1003\u201329.","journal-title":"Funct Integr Genomics"},{"issue":"1","key":"1492_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(1):1\u201313.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"1492_CR23","doi-asserted-by":"publisher","first-page":"e1001057","DOI":"10.1371\/journal.pcbi.1001057","volume":"7","author":"P Langfelder","year":"2011","unstructured":"Langfelder P, Luo R, Oldham MC, Horvath S. Is my network module preserved and reproducible? PLoS Comput Biol. 2011;7(1):e1001057.","journal-title":"PLoS Comput Biol"},{"key":"1492_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3389\/fgene.2018.00453","volume":"9","author":"MR Bakhtiarizadeh","year":"2018","unstructured":"Bakhtiarizadeh MR, Hosseinpour B, Shahhoseini M, Korte A, Gifani P. Weighted gene co-expression network analysis of endometriosis and identification of functional modules associated with its main hallmarks. Front Genet. 2018;9:453.","journal-title":"Front Genet"},{"issue":"1","key":"1492_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12863-022-01031-3","volume":"23","author":"SJ Salih","year":"2022","unstructured":"Salih SJ, Ghobadi MZ. Evaluating the cytotoxicity and pathogenicity of multi-walled carbon nanotube through weighted gene co-expression network analysis: a nanotoxicogenomics study. BMC Genomic Data. 2022;23(1):1\u201310.","journal-title":"BMC Genomic Data"},{"key":"1492_CR26","doi-asserted-by":"crossref","unstructured":"Zarei Ghobadi M, Mozhgani S-H, Erfani Y. Identification of dysregulated pathways underlying HTLV-1-associated myelopathy\/tropical spastic paraparesis through co-expression network analysis.Journal of neurovirology2021:1\u201311.","DOI":"10.1007\/s13365-020-00919-z"},{"key":"1492_CR27","doi-asserted-by":"crossref","unstructured":"Ghobadi MZ, Emamzadeh R, Teymoori-Rad M, Afsaneh E. Exploration of blood \u2013 derived coding and non-coding RNA diagnostic immunological panels for COVID-19 through a co-expressed-based machine learning procedure.Frontiers in Immunology2022,13.","DOI":"10.3389\/fimmu.2022.1001070"},{"issue":"1","key":"1492_CR28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B. 1995;57(1):289\u2013300.","journal-title":"J Roy Stat Soc B"},{"issue":"8","key":"1492_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/gcc.20675","volume":"48","author":"SH Kresse","year":"2009","unstructured":"Kresse SH, Ohnstad HO, Paulsen EB, Bjerkehagen B, Szuhai K, Serra M, Schaefer KL, Myklebost O, Meza-Zepeda LA. Cancer: LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization. Genes Chromosomes. 2009;48(8):679\u201393.","journal-title":"Genes Chromosomes"},{"issue":"6","key":"1492_CR30","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/jpm11060578","volume":"11","author":"C-Y Chang","year":"2021","unstructured":"Chang C-Y, Wu K-L, Chang Y-Y, Liu Y-W, Huang Y-C, Jian S-F, Lin Y-S, Tsai P-H, Hung J-Y, Tsai Y-M. The downregulation of LSAMP expression promotes lung cancer progression and is associated with poor survival prognosis. J Personalized Med. 2021;11(6):578.","journal-title":"J Personalized Med"},{"issue":"1","key":"1492_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1186\/s12885-018-4526-z","volume":"18","author":"C Li","year":"2018","unstructured":"Li C, Dong Q, Che X, Xu L, Li Z, Fan Y, Hou K, Wang S, Qu J, Xu L, et al. MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma. BMC Cancer. 2018;18(1):681.","journal-title":"BMC Cancer"},{"issue":"17","key":"1492_CR32","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1016\/j.febslet.2014.07.020","volume":"588","author":"X-r Li","year":"2014","unstructured":"Li X-r, Chu H-j, Lv T, Wang L, Kong S-f. Dai S-z: mir-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer. FEBS Lett. 2014;588(17):3298\u2013307.","journal-title":"FEBS Lett"},{"key":"1492_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.canlet.2017.10.024","volume":"412","author":"X Xue","year":"2018","unstructured":"Xue X, Fei X, Hou W, Zhang Y, Liu L, Hu R. Mir-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer. Cancer Lett. 2018;412:170\u20138.","journal-title":"Cancer Lett"},{"issue":"12","key":"1492_CR34","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s00018-010-0561-x","volume":"68","author":"S Shim","year":"2011","unstructured":"Shim S, Lee W, Chung H, Jung Y-K. Amyloid \u03b2-induced FOXRED2 mediates neuronal cell death via inhibition of proteasome activity. Cell Mol Life Sci. 2011;68(12):2115\u201327.","journal-title":"Cell Mol Life Sci"},{"issue":"17","key":"1492_CR35","first-page":"6316","volume":"9","author":"PM Voorhees","year":"2003","unstructured":"Voorhees PM, Dees EC, O\u2019Neil B, Orlowski RZ. The proteasome as a target for cancer therapy. Clin Cancer Res. 2003;9(17):6316\u201325.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1492_CR36","first-page":"5819","volume":"15","author":"J Zhai","year":"2018","unstructured":"Zhai J, Yang Z, Cai X, Yao G, An Y, Wang W, Fan Y, Zeng C, Liu K. ZNF280B promotes the growth of gastric cancer in vitro and in vivo. Oncol Lett. 2018;15(4):5819\u201324.","journal-title":"Oncol Lett"},{"issue":"11","key":"1492_CR37","doi-asserted-by":"publisher","first-page":"e78766","DOI":"10.1371\/journal.pone.0078766","volume":"8","author":"S Gao","year":"2013","unstructured":"Gao S, Hsieh C-L, Zhou J, Shemshedini L. Zinc finger 280B regulates sGC\u03b11 and p53 in prostate cancer cells. PLoS ONE. 2013;8(11):e78766.","journal-title":"PLoS ONE"},{"issue":"2","key":"1492_CR38","doi-asserted-by":"publisher","first-page":"e003042","DOI":"10.1161\/JAHA.115.003042","volume":"5","author":"XC Yan","year":"2016","unstructured":"Yan XC, Cao J, Liang L, Wang L, Gao F, Yang ZY, Duan JL, Chang TF, Deng SM, Liu Y. Mir-342\u20105p is a notch downstream molecule and regulates multiple angiogenic pathways including notch, vascular endothelial growth factor and transforming growth factor \u03b2 signaling. J Am Heart Association. 2016;5(2):e003042.","journal-title":"J Am Heart Association"},{"key":"1492_CR39","doi-asserted-by":"crossref","unstructured":"Yang H, Li Q, Niu J, Li B, Jiang D, Wan Z, Yang Q, Jiang F, Wei P, Bai S. microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10. OncoTargets 2016, 7(3):2709.","DOI":"10.18632\/oncotarget.6458"},{"issue":"7","key":"1492_CR40","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1007\/s13277-015-3154-3","volume":"36","author":"X Xie","year":"2015","unstructured":"Xie X, Liu H, Wang M, Ding F, Xiao H, Hu F, Hu R, Mei J. Mir-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells. Tumor Biology. 2015;36(7):5031\u20138.","journal-title":"Tumor Biology"},{"issue":"1","key":"1492_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-019-0848-4","volume":"19","author":"Y-l Zhao","year":"2019","unstructured":"Zhao Y-l, Zhang ZS-R, Bi S-H, Xiao J-X, Wang Z-Y, Jiao S-Y, Zhang H-L, Qiu D, Zhang J-F. UBN2 promotes tumor progression via the Ras\/MAPK pathway and predicts poor prognosis in colorectal cancer. Cancer Cell Int. 2019;19(1):1\u201312.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"1492_CR42","first-page":"176","volume":"12","author":"TT-H Le","year":"2022","unstructured":"Le TT-H, Hsieh C-L, Lin I-H, Chu C-Y, Do AD, Chen S-H, Shigemura K, Kitagawa K, Fujisawa M, Liu M-C. The ADAM9\/UBN2\/AKR1C3 axis promotes resistance to androgen-deprivation in prostate cancer. Am J Cancer Res. 2022;12(1):176.","journal-title":"Am J Cancer Res"},{"issue":"7","key":"1492_CR43","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.febslet.2015.02.013","volume":"589","author":"H Wang","year":"2015","unstructured":"Wang H, Yan C, Shi X, Zheng J, Deng L, Yang L, Yu F, Yang Y, Shao Y. MicroRNA-575 targets BLID to promote growth and invasion of non-small cell lung cancer cells. FEBS Lett. 2015;589(7):805\u201311.","journal-title":"FEBS Lett"},{"key":"1492_CR44","doi-asserted-by":"publisher","first-page":"108716","DOI":"10.1016\/j.biopha.2019.108716","volume":"113","author":"Y-n Wang","year":"2019","unstructured":"Wang Y-n, Xu F, Zhang P, Wang P, Wei Y-n, Wu C. Cheng S-j: MicroRNA-575 regulates development of gastric cancer by targeting PTEN. Biomed Pharmacotherapy. 2019;113:108716.","journal-title":"Biomed Pharmacotherapy"},{"key":"1492_CR45","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.2147\/OTT.S229614","volume":"13","author":"Y Qin","year":"2020","unstructured":"Qin Y, Mi W, Huang C, Li J, Zhang Y, Fu Y. Downregulation of miR-575 inhibits the tumorigenesis of gallbladder cancer via targeting p27 Kip1. OncoTargets therapy. 2020;13:3667.","journal-title":"OncoTargets therapy"},{"issue":"14","key":"1492_CR46","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/onc.2009.493","volume":"29","author":"MR Morris","year":"2010","unstructured":"Morris MR, Ricketts C, Gentle D, Abdulrahman M, Clarke N, Brown M, Kishida T, Yao M, Latif F, Maher ER. Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. Oncogene. 2010;29(14):2104\u201317.","journal-title":"Oncogene"},{"issue":"01","key":"1492_CR47","first-page":"10","volume":"4","author":"R Kong","year":"2021","unstructured":"Kong R, Liu H, Shi Y, Man Q, Liu S. COL14A1 promotes self-renewal of human liver cancer stem cells through activation of ERK signaling. J Bio-X Res. 2021;4(01):10\u20137.","journal-title":"J Bio-X Res"},{"key":"1492_CR48","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.12659\/MSM.897731","volume":"22","author":"L Hou","year":"2016","unstructured":"Hou L, Chen M, Yang H, Xing T, Li J, Li G, Zhang L, Deng S, Hu J, Zhao X. MiR-940 inhibited cell growth and migration in triple-negative breast cancer. Med Sci monitor: Int Med J experimental Clin Res. 2016;22:3666.","journal-title":"Med Sci monitor: Int Med J experimental Clin Res"},{"issue":"2","key":"1492_CR49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/biomedicines9020179","volume":"9","author":"K Urh","year":"2021","unstructured":"Urh K, \u017dlajpah M, Zidar N, Bo\u0161tjan\u010di\u010d E. Identification and validation of new cancer stem cell-related genes and their regulatory microRNAs in colorectal cancerogenesis. Biomedicines. 2021;9(2):179.","journal-title":"Biomedicines"},{"issue":"3","key":"1492_CR50","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1159\/000430230","volume":"37","author":"H-t Li","year":"2015","unstructured":"Li H-t, Zhang H, Chen Y, Liu X-f, Qian J. MiR-423-3p enhances cell growth through inhibition of p21Cip1\/Waf1 in colorectal cancer. Cell Physiol Biochem. 2015;37(3):1044\u201354.","journal-title":"Cell Physiol Biochem"},{"issue":"9","key":"1492_CR51","first-page":"5683","volume":"7","author":"G Guan","year":"2014","unstructured":"Guan G, Zhang D, Zheng Y, Wen L, Yu D, Lu Y, Zhao Y. microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma. Int J Clin experimental Pathol. 2014;7(9):5683.","journal-title":"Int J Clin experimental Pathol"},{"issue":"10","key":"1492_CR52","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.21873\/anticanres.11089","volume":"36","author":"W-T Kuo","year":"2016","unstructured":"Kuo W-T, Yu S-Y, Li S-C, Lam H-C, Chang H-T, Chen W-S, Yeh C-Y, Hung S-F, Liu T-C, Wu T. MicroRNA-324 in human cancer: mir-324-5p and mir-324-3p have distinct biological functions in human cancer. Anticancer Res. 2016;36(10):5189\u201396.","journal-title":"Anticancer Res"},{"issue":"6","key":"1492_CR53","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00535-017-1408-0","volume":"53","author":"G-L Sun","year":"2018","unstructured":"Sun G-L, Li Z, Wang W-Z, Chen Z, Zhang L, Li Q, Wei S, Li B-W, Xu J-H, Chen L. Mir-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt\/beta-catenin signaling pathway. J Gastroenterol. 2018;53(6):725\u201339.","journal-title":"J Gastroenterol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01492-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01492-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01492-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T05:11:26Z","timestamp":1729141886000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01492-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1492"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01492-0","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"3 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflicts of interest and have never published the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}